The effectiveness of FloSeal® matrix hemostatic agent in thyroid surgery: a prospective, randomized, control study
- 430 Downloads
The objective of this study was to compare the effectiveness of FloSeal® matrix hemostatic agent with hemostatic surgical procedures and Tabotamp® in thyroid surgery.
One hundred fifty-five consecutive total thyroidectomy patients were recruited at our institution between January 2005 and December 2007. Exclusion criteria were applied. Patients were randomized to one of three hemostatic approaches: 49 received surgical procedures only, and 52 received oxidized regenerated cellulose patch (Tabotamp Fibrillar 2.5 × 5 cm) and 54 FloSeal (5,000 U/5 mL). The same surgeon performed all operations.
Mean operating time was reduced in the FloSeal group (105 min) vs. surgical (133 min, p = 0.02) and vs. Tabotamp (122 min, p = 0.0003). Also, wound drain removal occurred earlier with FloSeal (p = 0.006 vs. surgical; p = 0.008 vs. Tabotamp) resulting in shorter postoperative hospital stay in the FloSeal group (p = 0.02 vs. surgical; p = 0.002 vs. Tabotamp).
FloSeal matrix is an effective additional agent to conventional haemostatic procedures in thyroid surgery.
KeywordsThyroidectomy Hemorrhagic complication FloSeal Tabotamp Hemostatic agent
- 25.Tonante A, Lo Schiavo MG, Bonanno L et al (2006) Hemorrhagic complications in thyroid surgery. Control of bleeding from retroneural vessels using collagen and thrombin gelatine granules. Chir Ital 58:61–68Google Scholar
- 28.Armitage P, Berry G (1994) Statistical methods in medical research, 3rd edn. Blackwell, OxfordGoogle Scholar
- 29.Dawson B, Trapp RG (2001) Basic & Clinical Biostatistics, 3rd edn. McGraw-Hill, New YorkGoogle Scholar